Summary
Updated Aug 31, 2026
Ira Duarte is EVP, Chief Financial Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX). 11 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026.
Recent Transactions
17Every recent SEC Form 4 transaction Ira Duarte has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Ira Duarte go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Ira Duarte. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Rubric Capital Management LP - $5.00M of HRTX open-market activity on record
- Adam Morgan - $3.70M of HRTX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ira Duarte?
Ira Duarte is a corporate insider, tracked as EVP, Chief Financial Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ira Duarte submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Ira Duarte's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ira Duarte and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial